ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,522.30
1.58%
Dow Jones
40,842.79
0.24%
US Dollar vs MXN
18.65295
0.05%
Brent Oil
81.655
0.18%
Bitcoin
64,349.92
-0.38%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. DexCom Inc (DXCM)

  7. DexCom Inc (DXCM) Noticias

DXCM

DexCom (DXCM)

DexCom Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DXCM
FechaHoraFuenteTítuloSímboloCompañía
31/07/202415:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DXCMDexCom Inc
29/07/202408:00Business WireTandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health CanadaNASDAQ:DXCMDexCom Inc
29/07/202408:00Business WireTandem Diabetes Care et Dexcom annoncent que la pompe à insuline t:slim X2 compatible avec le système de SGC Dexcom G7 est autorisée à la vente par Santé CanadaNASDAQ:DXCMDexCom Inc
28/07/202411:14PR Newswire (US)Edelson Lechtzin LLP Announces Investigation Dexcom, Inc. (NASDAQ: DXCM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmNASDAQ:DXCMDexCom Inc
26/07/202404:57IH Market NewsDexcom Shares Drop 37% on Weak Revenue and Forecast; Coursera Rises 24% After Beating Q2 Revenue EstimatesNASDAQ:DXCMDexCom Inc
25/07/202416:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DXCMDexCom Inc
25/07/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXCMDexCom Inc
25/07/202415:03Business WireDexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase ProgramNASDAQ:DXCMDexCom Inc
25/07/202405:21IH Market NewsU.S. Index Futures Mixed After Tech Sell-Off, Oil Prices Drop on Weak China Demand and Ceasefire ExpectationsNASDAQ:DXCMDexCom Inc
27/06/202407:30Business WireDexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.NASDAQ:DXCMDexCom Inc
20/06/202406:15Business WireDexcom Expands AID Partnership Into The NetherlandsNASDAQ:DXCMDexCom Inc
20/06/202405:05Business WireDexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
18/06/202418:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXCMDexCom Inc
05/06/202405:00Business WireDexcom G7 Now Connects Directly to Apple Watch in the U.S.NASDAQ:DXCMDexCom Inc
04/06/202409:16Business WireDexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
04/06/202406:00Business WireDexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
29/05/202415:59Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:DXCMDexCom Inc
29/05/202407:30Business WireDexcom Announces Upcoming Conference PresentationNASDAQ:DXCMDexCom Inc
29/05/202407:30Business WireTandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGMNASDAQ:DXCMDexCom Inc
20/05/202403:00Business WireDexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 DiabetesNASDAQ:DXCMDexCom Inc
26/04/202406:47IH Market NewsExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in EarningsNASDAQ:DXCMDexCom Inc
25/04/202415:03Business WireDexcom Reports First Quarter 2024 Financial ResultsNASDAQ:DXCMDexCom Inc
25/04/202406:53IH Market NewsU.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy ForecastNASDAQ:DXCMDexCom Inc
03/04/202408:00Business WireDexcom Publishes Annual Sustainability ReportNASDAQ:DXCMDexCom Inc
02/04/202407:30Business WireDexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern TimeNASDAQ:DXCMDexCom Inc
05/03/202415:26Business WireStelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-CounterNASDAQ:DXCMDexCom Inc
05/03/202412:20Business WireDexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTDNASDAQ:DXCMDexCom Inc
08/02/202416:14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DXCMDexCom Inc
08/02/202415:02Business WireDexcom Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:DXCMDexCom Inc
08/02/202404:56IH Market NewsU.S. Index Futures Dip Slightly, Oil Prices ClimbNASDAQ:DXCMDexCom Inc
 Showing the most relevant articles for your search:NASDAQ:DXCM

Su Consulta Reciente

USI
USTECH100
US Tech 100
FX
USDMXN
US Dollar vs MXN
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
CCOM
US500
US 500
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs US Dollar
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados